Sentry LLC Merck & Co., Inc. Transaction History

Sentry LLC

$365 Billion
Q4 2025

A detailed history of Sentry LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sentry LLC holds 49,160 shares of MRK stock, worth $4.56 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares

49,160

Previous 49,155 0.01%

Holding current value

$4.56 Million

Previous $4.13 Billion 25.43%

% of portfolio

1.42%

Previous 1.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 16, 2026	BUY	$82.49 - $92.93 $412 - $464	5 Added 0.01%	49,160 $5.17 Billion
Q3 2025 Oct 22, 2025	SELL	$77.6 - $87.37 $42,214 - $47,529	-544 Reduced 1.09%	49,155 $4.13 Billion
Q2 2025 Jul 30, 2025	SELL	$73.47 - $87.12 $190,140 - $225,466	-2,588 Reduced 4.95%	49,699 $3.93 Billion
Q1 2025 Apr 17, 2025	BUY	$83.01 - $101.02 $243,219 - $295,988	2,930 Added 5.94%	52,287 $4.69 Billion
Q4 2024 Jan 23, 2025	SELL	$96.31 - $114.76 $587,394 - $699,921	-6,099 Reduced 11.0%	49,357 $4.91 Billion

Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $38,457 - $44,623	-346 Reduced 0.62%	55,456 $6.3 Billion
Q2 2024 Jul 24, 2024	SELL	$123.8 - $132.96 $33,673 - $36,165	-272 Reduced 0.49%	55,802 $6.91 Billion
Q1 2024 Apr 22, 2024	SELL	$113.24 - $131.95 $102,029 - $118,886	-901 Reduced 1.58%	56,074 $7.4 Billion
Q4 2023 Feb 01, 2024	BUY	$100.18 - $109.02 $5.71 Million - $6.21 Million	56,975 New	56,975 $6.21 Million
Q3 2023 Mar 06, 2024	BUY	$102.95 - $114.33 $248,315 - $275,763	2,412 Added 4.4%	57,269 $5.9 Billion
Q2 2023 Mar 06, 2024	BUY	$108.61 - $118.38 $5,213 - $5,682	48 Added 0.09%	54,857 $6.33 Billion
Q1 2023 Mar 06, 2024	SELL	$102.94 - $114.86 $222,968 - $248,786	-2,166 Reduced 3.8%	54,809 $5.83 Billion

Others Institutions Holding MRK

# of Institutions

3,915

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry LLC with notifications on news.

Account